Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/HCTZ vs Valsartan in Severe Hypertension
NCT00273299Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan, hydrochlorothiazide in hypertension (HTN), sponsored by Novartis. Started Nov 2005; status: completed.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00273299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273299.